Little-known Genuine Biotech’s AIDS drug turns out to help Covid patients and may turn into a multibillion-dollar product

China and EU leaders to hold delayed summit online, sending positive bilateral investment signal; Junshi Biosciences starts trial of Covid-19 treatment

Shanghai Junshi said it will sell its medicine for a third of the price of one of its U.S. competitors

New rules lure in Junshi Biosciences, which plans to raise $414 million in IPO